NCT00540891View on ClinicalTrials.gov

The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score

PHASE3CompletedINTERVENTIONAL

Enrollment

372

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

October 31, 2004

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

ALFUZOSIN

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00540891 - The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score | Biotech Hunter | Biotech Hunter